Endotoxin Neutralization as a Biomonitor for Inflammatory Bowel Disease

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Champion, Keith ^a   Chiu, Laura ^b   Ferbas, John ^b   Pepe, Michael ^a  

^a BioDtech Inc   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BACTERIAL INFECTION; BIOLOGICAL MONITORING; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEAT SENSITIVITY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEIN DENATURATION; SEPSIS; SEX DIFFERENCE; ULCERATIVE COLITIS;

ACIDS; ADULT; AGE DISTRIBUTION; AGED; BIOLOGICAL MARKERS; ENDOTOXINS; FEMALE; HOT TEMPERATURE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; SEVERITY OF ILLNESS INDEX;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA;

EID: 84879468113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067736     Document Type: Article

References (60)

1. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, et al. (1995) Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36: 897-901. doi:10.1136/gut.36.6.897. PubMed: 7615280.
2. Parracho HM, Bingham MO, Gibson GR, McCartney AL, (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54: 987-991. doi:10.1099/jmm.0.46101-0. PubMed: 16157555.
3. Odeh M, (1995) Endotoxin and tumor necrosis factor α in the pathogenesis of hepatic encephalopathy. J Clin Gastroenterol 19: 146-153.
4. Liao W, (1996) Endotoxin: possible roles in initiation and development of atherosclerosis. J Lab Clin Med 128: 452-460. doi:10.1016/S0022-2143(96)90042-6. PubMed: 8900288.
5. Wilmott RW, Frenzke M, Kociela V, Peng L, (1994) Plasma interleukins, tumor necrosis factor α, and lipopolysaccharide concentrations during pulmonary exacerbations of cystic fibrosis. Pediatr Pulmonol 18: 21-27. doi:10.1002/ppul.1950180107. PubMed: 7970903.
6. Jirillo E, Covelli V, Brandonisio O, Munno I, De Simone C, et al. (1991) HIV-infection and in vivo lipopolysaccharide-induced release of cytokines. An amplified mechanism of damage to the host. Acta Neurol 13: 188-196.
7. Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DK, (1997) A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest 76: 319-327. PubMed: 9121115.
8. Mehrzad J, Dosogne H, De Spiegeleer B, Duchateau L, Burvenich C, (2007) Bovine blood neutrophil acyloxyacyl hydrolase (AOAH) activity during endotoxin and coliform mastitis. Vet Res 38: 655-668. doi:10.1051/vetres:2007024. PubMed: 17583663.
9. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, et al. (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159. doi:10.1126/science.286.5447.2156. PubMed: 10591647.
10. Barclay GR, (1995) Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog Clin Biol Res 392: 263-272. PubMed: 8524931.
11. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, et al. (2000) Enteric bacteria, lipopolysaccharide and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6: 205-214. doi:10.1177/09680519000060030101. PubMed: 11052175.
12. Welcker K, Martin A, Kölle P, Siebeck M, Gross M, (2004) Increased intestinal permeability in patients with inflammatory bowel disease. Eur J Med Res 9: 456-460. PubMed: 15546811.
13. Oriishi T, Sata M, Toyonaga A, Sasaki E, Tanikawa K, (1995) Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A. Gut 36: 891-896. doi:10.1136/gut.36.6.891. PubMed: 7615279.
14. Salim SY, Söderholm JD, (2011) Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 17: 362-381. doi:10.1002/ibd.21403. PubMed: 20725949.
15. Pastor Rojo O, López San Román A, Albéniz Arbizu E, de la Hera Martínez A, Ripoll Sevillano E, et al. (2007) Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis 13: 269-277. doi:10.1002/ibd.20019. PubMed: 17206721.
16. Kruis W, Schullser P, Weinzierl M, Galanos C, Eisenburg J, (1984) Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease. Dig Dis Sci 29: 502-507. doi:10.1007/BF01296269. PubMed: 6144475.
17. Mattsby-Baltzer I, Alving CR, (1984) Antibodies to lipid A: occurrence in humans. Rev Infect Dis 6: 553-557. doi:10.1093/clinids/6.4.553. PubMed: 6474015.
18. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I, (1996) Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365-375. doi:10.1136/gut.38.3.365. PubMed: 8675088.
19. Marget W, (1987) Lipid A antibody in the human. Infection 15: 142-145. doi:10.1007/BF01650220. PubMed: 3596812.
20. Landy M, (1960) Inactivation of endotoxin by humoral systems. Ann N Y Acad Sci 88: 1273-1277. PubMed: 13758707.
21. Keene WR, Landy M, Shear MJ, (1961) Inactivation of endotoxin by a humoral component. VII. Enzymatic degradation of endotoxin by blood plasma. J Clin Invest 40: 302-310. doi:10.1172/JCI104257. PubMed: 13752167.
22. Yamaguchi Y, Billing PA, Babb JL, Mori K, Akagi M, et al. (1986) Endotoxin inactivating activity of rat serum. Proc Soc Exp Biol Med 181: 163-168. PubMed: 3945619.
23. Skarnes RC, Rosen FS, Shear MJ, Landy M, (1958) Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma. J Exp Med 108: 685-699. doi:10.1084/jem.108.5.685. PubMed: 13587851.
24. Johns MA, Sipe JD, Melton LB, Strom TB, McCabe WR, (1988) Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation. Infect Immun 56: 1593-1601. PubMed: 3286501.
25. Schröder J, Kahlke V, Staubach KH, Zabel P, Stüber F, (1998) Gender differences in human sepsis. Arch Surg 133: 1200-1205. doi:10.1001/archsurg.133.11.1200. PubMed: 9820351.
26. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW, (2000) Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26: 167-172. doi:10.1007/s001340050041. PubMed: 10784304.
27. Foxman B, (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113: 5S-13S. doi:10.1016/S0002-9343(02)01054-9. PubMed: 1211386612601337.
28. McGue M, Borecki IB, Gerrard JW, Rao DC, (1990) Sex-linked determinants for IgM? Hum Hered 40: 231-234. doi:10.1159/000153935. PubMed: 2379928.
29. Modica MA, Freddi S, Caruso C, (1989) Blood IgA, IgM and IgE levels are influenced by sex and HLA phenotype. Exp Clin Immunogenet 6: 251-257. PubMed: 2488685.
30. Berger D, Schleich S, Seidelmann M, Beger HG, (1990) Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus-amebocyte-lysate-test and plasma protein levels. FEBS Lett 277: 33-36. doi:10.1016/0014-5793(90)80803-Q. PubMed: 1702736.
31. Al-Muzairai IA, Mansour M, Almajed L, Alkanderi N, Alshatti N, et al. (2008) Heat inactivation can differentiate between IgG and IgM antibodies in the pretransplant cross match. Transplant Proc 40: 2198-2199. doi:10.1016/j.transproceed.2008.07.045. PubMed: 18790190.
32. Schetters T, Van Run-Breda J, Van Zon A, Eling W, (1988) Selective depletion of immunoglobulin isotypes after decomplementation of mouse sera by heat treatment. J Immunol Methods 109: 193-197. doi:10.1016/0022-1759(88)90242-6. PubMed: 3129517.
33. Vermeer AW, Norde W, (2000) The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys J 78: 394-404. doi:10.1016/S0006-3495(00)76602-1. PubMed: 10620303.
34. Emancipator K, Csako G, Elin RJ, (1992) In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 60: 596-601. PubMed: 1730494.
35. Petsch D, Deckwer WD, Anspach FB, (1998) Proteinase K digestion of proteins improves detection of bacterial endotoxin by Limulus amebocyte lysate assay: applications for endotoxin removal from cationic peptides. Anal Biochem 259: 42-47. doi:10.1006/abio.1998.2655. PubMed: 9606141.
36. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, et al. (1990) Structure and function of lipopolysaccharide binding proteins. Science 249: 1429-1431. doi:10.1126/science.2402637. PubMed: 2402637.
37. Maury E, Blanchard HS, Chauvin P, Guglielminotti J, Alzieu M, et al. (2003) Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock. J Crit Care 18: 115-120. doi:10.1053/jcrc.2003.50004. PubMed: 12800122.
38. Jackson SK, Parton J, Barnes RA, Poynton CH, Fegan C, (1993) Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation. Eur J Clin Invest 23: 540-545. doi:10.1111/j.1365-2362.1993.tb00963.x. PubMed: 8243524.
39. Porat R, Yanoov M, Johns MA, Shibolet S, Michalevicz R, (1992) Effects of endotoxin-associated protein on hematopoiesis. Infect Immun 60: 1756-1760. PubMed: 1563761.
40. Bjornson BH, Agura E, Harvey JM, Johns M, Andrews RG, et al. (1988) Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent. Infect Immun 56: 1602-1607. PubMed: 2836311.
41. Raynaud M, Kouznetzova B, Navarro MJ, Chermann JC, Digeon M, et al. (1973) A common antigenic constituent in various purified Salmonella endotoxins. J Infect Dis 128: 35-42. doi:10.1093/infdis/128.Supplement_1.S35. PubMed: 4198204.
42. Hardy KW, White TD, (2001) Some commercial preparations of Escherichia coli bacterial endotoxin lipopolysaccharide (LPS) are contaminated with biologically active substances. J Neurochem 78: 1183-1184. doi:10.1046/j.1471-4159.2001.00486.x. PubMed: 11556327.
43. Adrie C, Azoulay E, Francais A, Clec'h C, Darques L,et al (2007) Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 132: 1786-1793. doi:10.1378/chest.07-0420. PubMed: 17890473.
44. Neylan TC, Sun B, Rempel H, Ross J, Lenoci M, et al. (2011) Suppressed monocyte gene expression profile in men versus women with PTSD. Brain Behav Immun 25: 524-531. doi:10.1016/j.bbi.2010.12.001. PubMed: 21145962.
45. Oertelt-Prigione S, (2012) The influence of sex and gender on the immune response. Autoimmun Rev 11: A479-A485. doi:10.1016/j.autrev.2011.11.022. PubMed: 22155201.
46. Martsev SP, Kravchuk ZI, Vlasov AP, Lyakhnovich GV, (1995) Thermodynamic and functional characterization of a stable IgG conformer obtained by renaturation from a partially structured low pH-induced state. FEBS Lett 361: 173-175. doi:10.1016/0014-5793(95)00145-Y. PubMed: 7698318.
47. Orholm M, Binder V, Sørensen TI, Rasmussen LP, Kyvik KO, (2000) Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 35: 1075-1081. doi:10.1080/003655200451207. PubMed: 11099061.
48. Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, et al. (2006) Family and twin studies in inflammatory bowel disease. World J Gasteroenterol 12: 3668-3672. PubMed: 16773682.
49. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, et al. (2011) Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel disease. Inflamm Bowel Dis 17: 179-184. doi:10.1002/ibd.21339. PubMed: 20839241.
50. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134: 743-756. doi:10.1016/j.cell.2008.07.021. PubMed: 18775308.
51. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2011) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
52. Shoda R, Matsueda K, Yamato S, Umeda N, (1996) Epidemiologic analysis of Crohn's disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J Clin Nutr 63: 741-745. PubMed: 8615358.
53. Birrenbach T, Böcker U, (2004) Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10: 848-859. doi:10.1097/00054725-200411000-00019. PubMed: 15626903.
54. Katschinski B, Fingerle D, Scherbaum B, Goebell H, (1993) Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci 38: 1596-1600. doi:10.1007/BF01303165. PubMed: 8359069.
55. Rampton DS, (2011) The influence of stress on the development and severity of immune-mediated diseases. J Rheumatol Suppl 88: 43-47. doi:10.3899/jrheum.110904. PubMed: 22045978.
56. Macfarlane S, Steed H, Macfarlane GT, (2009) Intestinal bacteria and inflammatory bowel disease. Crit Rev Clin Lab Sci 46: 25-54. doi:10.1080/10408360802485792. PubMed: 19107650.
57. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65. doi:10.1038/nature08821. PubMed: 20203603.
58. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, et al. (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 1: 403-418. doi:10.1038/ismej.2007.52. PubMed: 18043660.
59. Vilela EG, Torres HO, Martins FP, Ferrari Mde L, Andrade MM, et al. (2012) Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis. World J Gasteroenterol 18: 872-881. doi:10.3748/wjg.v18.i9.872.
60. Vermeire S, Van Assche G, Rutgeerts P, (2005) The role of C-reactive protein as an inflammatory marker in gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2: 580-586. doi:10.1038/ncpuro0337. PubMed: 16327837.